BRIEF published on 11/04/2024 at 11:51, 1 year 6 months ago Acticor Biotech : Publication des résultats financiers semestriels 2024 Résultats Semestriels Biotechnologie Finance Redressement Judiciaire Glenzocimab
BRIEF published on 11/04/2024 at 11:51, 1 year 6 months ago Acticor Biotech: Publication of 2024 half-year financial results Biotechnology Finance Half-year Results Glenzocimab Judicial Recovery
PRESS RELEASE published on 11/04/2024 at 11:46, 1 year 6 months ago Informations privilégiées / Communiqué sur comptes, résultats Acticor Biotech publie ses résultats financiers semestriels 2024 et annonce le repositionnement du glenzocimab dans le traitement de l’infarctus du myocarde avec élévation du segment ST (STEMI) Résultats Financiers ACTICOR BIOTECH Glenzocimab Repositionnement Infarctus Du Myocarde
PRESS RELEASE published on 11/04/2024 at 11:46, 1 year 6 months ago Inside Information / News release on accounts, results Acticor Biotech publishes its half-year financial results for 2024, highlighting repositioning of glenzocimab in STEMI treatment, receivership proceedings extension, and shareholder approvals Repositioning Shareholder Approvals ACTICOR BIOTECH Glenzocimab Half-year Financial Results
BRIEF published on 10/11/2024 at 17:50, 1 year 7 months ago Acticor Biotech Advances Glenzocimab in Myocardial Infarction Treatment Clinical Trials Myocardial Infarction ACTICOR BIOTECH Glenzocimab Cardiovascular Treatment
BRIEF published on 10/11/2024 at 17:50, 1 year 7 months ago Acticor Biotech fait progresser le Glenzocimab dans le traitement de l'infarctus du myocarde Essais Cliniques ACTICOR BIOTECH Glenzocimab Infarctus Du Myocarde Traitement Cardiovasculaire
PRESS RELEASE published on 10/11/2024 at 17:45, 1 year 7 months ago Inside Information / Other news releases Acticor Biotech repositions glenzocimab in the treatment of myocardial infarction, evaluating efficacy and safety in phase 2 studies LIBERATE and GLORIA. Clinical trials aim to reduce infarct size and prevent complications Clinical Trials Phase 2b Myocardial Infarction ACTICOR BIOTECH Glenzocimab
PRESS RELEASE published on 10/11/2024 at 17:45, 1 year 7 months ago Informations privilégiées / Autres communiqués Repositionnement de glenzocimab dans le traitement de l'infarctus du myocarde par Acticor Biotech. Nouvelle étude de phase 2b LIBERATE et préparation de l'étude GLORIA Traitement Étude Clinique ACTICOR BIOTECH Glenzocimab Infarctus Du Myocarde
BRIEF published on 07/09/2024 at 20:50, 1 year 10 months ago Acticor Biotech Reports 2023 Financial Results Financial Report Annual Results Capital Raising ACTICOR BIOTECH Glenzocimab
BRIEF published on 07/09/2024 at 20:50, 1 year 10 months ago Acticor Biotech publie ses résultats financiers pour 2023 Résultats Annuels Rapport Financier ACTICOR BIOTECH Glenzocimab Levée De Capitaux
Published on 05/15/2026 at 01:35, 1 hour 19 minutes ago NXT Energy Solutions Announces First Quarter 2026 Results
Published on 05/15/2026 at 01:30, 1 hour 24 minutes ago Nano One Reports Q1 2026 Results and Reminds Shareholders of Upcoming AGM
Published on 05/15/2026 at 00:45, 2 hours 9 minutes ago Golden Minerals Announces Sale of Minera William, S.A. de C.V. and Equity Financing
Published on 05/15/2026 at 00:20, 2 hours 34 minutes ago Gold Basin Resources Announces Filing and Mailing of Meeting Materials for Special Meeting to Approve Arrangement with CANEX
Published on 05/15/2026 at 00:00, 2 hours 54 minutes ago Redwood AI Announces Optimization Module Update to Reactosphere, Expanding Experimental Planning and Chemical Process Optimization Capabilities
Published on 05/15/2026 at 02:05, 48 minutes ago WIRobotics Secures Approximately KRW 100 Billion (USD 68 Million) Series B Funding
Published on 05/15/2026 at 00:05, 2 hours 48 minutes ago ESGE Days 2026: Endoscopic procedure associated with greater short-term weight loss than oral semaglutide, study finds
Published on 05/14/2026 at 23:05, 3 hours 48 minutes ago DeFi Technologies Inc. Announces First Quarter 2026 Financial Results with Revenue of $11.2 Million, Net Income of $4.9 Million, and Strong Balance Sheet
Published on 05/14/2026 at 19:55, 6 hours 58 minutes ago Gastech 2026 to convene global energy leaders in Bangkok as Asia accelerates demand, LNG investment and system transformation
Published on 05/14/2026 at 19:30, 7 hours 23 minutes ago FutureGrail Sets New Sales Record for George Daniels Timepiece at May Auction
Published on 05/14/2026 at 09:03, 17 hours 51 minutes ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 1 day 8 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
Published on 05/13/2026 at 18:00, 1 day 8 hours ago ALTAREIT - Assemblée Générale Mixte du 4 juin 2026 - Modalités de mise à disposition des documents préparatoires
